International Journal of Trend in Scientific Research and Development

Simulating the effects of biotic and a biotic interactions with or without human interference to compute ecological resilience within a closed ecosystem. Simulating a set food chain in the said ecosystem and studying the effects of biotic factors on the biotic chains and vice versa. Classifying and comparing various closed ecosystems on the said parameters and determinacy of the stability of an ecosystem over time. Study of various a biotic compound statistics via graphical representations in a time controlled order. Ability to introduce new species, remove existing ones or change the concentration amounts of current biotic parameters and thus study various results in a cause effect relationship. Time factoring and control over biotic gene pool to affect ecosystems on both a macro and micro scale. In depth latency about ecosystems in the gaming industry, weather simulators, and life perseverance of various endangered and threatened species along with sustainable resource control. 

by Ankita Dhillon | Kirti Bhatia | Rohini Sharma "Eko: Artificial Life, Determinacy of Ecological Resilience and Classification of Closed Ecosystems" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, 

URL: https://www.ijtsrd.com/papers/ijtsrd46318.pdf 

Paper URL: https://www.ijtsrd.com/computer-science/bioinformatics/46318/eko-artificial-life-determinacy-of-ecological-resilience-and-classification-of-closed-ecosystems/ankita-dhillon

callforpapermedicalscience, medicalsciencejournal, manuscriptsubmission

Drug repositioning or drug repurposing or drug profiling is the discovery of new applications for approved or failed drug.. Drug repositioning is the development of new approved drug applications. The cost of bringing a medicine to the market is around one million which include clinical and preclinical trials. Repositioning of drugs help in cutting down costs as well as time involve in intial validation and authorization. The procedure involved in Drug repositioning is generally performed during the drug development phase to modify or extend an active molecules distribution line. On a fundamental level, repositioning opportunities exist because drugs perturb multiple biological entities and engage themselves in multiple biological processes. Therefore, a drug can play multiple roles or perform a various mode of actions that are responsible for its pharmacology. Hypertension, is a condition that causes increase in the risk of cardiovascular diseases. In this study an attempt has been made to reposition hypertensive drugs for different diseases by exploring molecular targets of hypertensive drugs. Consider that they often need to be administered for long periods of time, often over whole life time Side effects although present, have been found safe enough to be used for such long durations, hence repurposing these drugs for other diseases may be beneficial with limited side effects. 

by Bhawna Singh | Asmita Das "Exploring Molecular Targets for Repositioning of Hypertensive Drugs" 

Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-3 , April 2021, 

URL: https://www.ijtsrd.com/papers/ijtsrd39910.pdf 

Paper URL: https://www.ijtsrd.com/biological-science/bioinformatics/39910/exploring-molecular-targets-for-repositioning-of-hypertensive-drugs/bhawna-singh

peerreviewedinternationaljournal, paperpublicationforstudent